Encapsulated neural transplants

Progress in Brain Research

Volumn 127, Issue , 2000, Pages 189-202

  Tseng, Jack L ^a   Aebischer, Patrick ^a  

^a University of Lausanne Medical Center   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; 3 NITROPROPIONIC ACID; AMPHETAMINE; BRAIN DERIVED NEUROTROPHIC FACTOR; CATECHOLAMINE; ENKEPHALIN; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; NEUROPEPTIDE Y; OXIDOPAMINE; PLACEBO; RECOMBINANT CILIARY NEUROTROPHIC FACTOR; SOMATOSTATIN; TYROSINE 3 MONOOXYGENASE;

ACUTE PHASE RESPONSE; ADRENAL GLAND; AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL MODEL; CATTLE; CELL ENCAPSULATION; CELL STRAIN BHK; CHROMAFFIN CELL; CHRONIC PAIN; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DEGENERATIVE DISEASE; DOUBLE BLIND PROCEDURE; ENCAPSULATION; FETAL TISSUE TRANSPLANTATION; FEVER; GENE THERAPY; HUMAN; HUNTINGTON CHOREA; MAJOR CLINICAL STUDY; MICROCAPSULE; MOUSE; NERVE TRANSPLANTATION; NEUROLOGIC DISEASE; NONHUMAN; PAIN; PARKINSON DISEASE; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RAT; REVIEW; TREATMENT OUTCOME; WEIGHT REDUCTION;

EID: 0034589757     PISSN: 00796123     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0079-6123(00)27010-6     Document Type: Article

References (63)

1. Aebischer, P., Tresco, P.A., Sagen, J. and Winn, S.R. (1991) Transplantation of microencapsulated bovine chromaffin cells reduces lesion-induced rotational asymmetry in rats. Brain Res., 560: 43-49.
2. Aebischer, P., Buchser, E., Joseph, J.M., Favre, J., de Tribolet, N., Lysaght, M., Rudnick, S. and Goddard, M. (1994) Transplantation in humans of encapsulated xenogeneic cells without immunosuppression. A preliminary report. Transplantation, 8: 1275-1277.
3. Aebischer, P., Pochon, N.A.-M., Heyd, B., Déglon, N., Joseph, J.-M., Zurn, A.D., Baetge, E.E., Hammang, J.P., Goddard, M., Lysaght, M., Kaplan, F., Kato, A.C., Schluep, M., Hirt, L., Regli, F., Porchet, F. and De Tribolet, N. (1996a) Gene therapy for amyotrophic lateral sclerosis (ALS) using a polymer encapsulated xenogenic cell line engineered to secrete HCNTF. Hum. Gene Ther., 7: 851-860.
4. Aebischer, P., Schluep, M., Déglon, N., Joseph, J.-M., Hirt, L., Heyd, B., Goddard, M., Hammang, J.P., Zurn, A.D., Kato, A.C., Regli, F. and Baetge, E.E. (1996b) Intrathecal delivery of CNTF using encapsulated genetically modified xenogeneic cells in amyotrophic lateral sclerosis patients. Nat. Med., 2: 696-699.
5. Al-Hendy, A., Hortelano, G., Tannenbaum, G.S. and Chang, P.L. (1996) Growth retardation - An unexpected outcome from growth hormone gene therapy in normal mice with microencapsulated myoblasts. Hum. Gene Ther., 7: 61-70.
6. ALS CNTF Treatment Study (ACTS) Group (1996) A double-blind placebo-controlled clinical trial of subcutaneous recombinant human ciliary neurotrophic factor (rHCNTF) in amyotrophic lateral sclerosis. Neurology, 46:1244-1249.
7. Anderson, K.D., Panayotatos, N., Corcoran, T.L., Lindsay, R.M. and Wiegan, S.J. (1996) Ciliary neurotrophic factor protects striatal output neurons in an animal model of Huntington's disease. Proc. Natl. Acad. Sci. U.S.A., 93: 7346-7351.
8. Beck, K.D., Valverde, J., Alexi, T., Poulsen, K., Moffat, B., Vandlen, R.A., Rosenthal, A. and Hefti, F. (1995) Mesencephalic dopaminergic neurons protected by GDNF from axotomy-induced degeneration in the adult brain. Nature, 373: 339-341.
9. Biewenga, J.E., Destree, O.H. and Schrama, L.H. (1997) Plasmid-mediated gene transfer in neurons using the biolistics technique. J. Neurosci. Methods, 71: 67-75.
10. Bowenkamp, K.E., Hoffman, A.F., Gerhardt, G.A., Henry, M.A., Biddle, P.T., Hoffer, B.J. and Granholm, A.C. (1995) Glial cell line-derived neurotrophic factor supports survival of injured midbrain dopaminergic neurons. J. Comp. Neurol., 355: 479-489.
11. Buchser, E., Goddard, M., Heyd, B., Joseph, J.M., Favre, J., de Tribolet, N., Lysaght, M. and Aebischer, P. (1996) Immunoisolated xenogenic chromaffin cell therapy for chronic pain. Initial clinical experience. Anesthesiology, 85: 1005-1012.
12. 3H]PK11195 as a marker for gliosis. Biomaterials, 19: 829-837.
13. Chang, T.M.S. (1964) Semipermeable microcapsules. Science, 146:524-525.
14. Chang, P.L., Shen, N. and Westcott, A.J. (1993) Delivery of recombinant gene products with microencapsulated cells in vivo. Hum. Gene Ther., 4: 433-440.
15. Chick, W.L., Like, A.A. and Lauris, V. (1975) Beta cell culture in synthetic capillaries: An artificial endocrine pancreas. Science, 187:847-849.
16. Crooks, C.A., Douglas, J.A., Broughton, R.L. and Sefton, M.V. (1990) Microencapsulation of mammalian cells in a HEMA-MMA copolymer: Effects on capsule morphology and permeability. J. Biomed. Mater. Res., 24: 1241-1262.
17. Dantes, M. and McComas, A. (1991) The extent and time course of motoneuron involvement in amyotrophic lateral sclerosis. Muscle Nerve, 14: 416-421.
18. Date, I., Miyoshi, Y., Ono, T., Imaoka, T., Furuta, T., Asari, S., Ohmoto, T. and Iwata, H. (1996) Preliminary report of polymer-encapsulated dopamine-secreting cell grafting into the brain. Cell Transplant., 5: S17-S19.
19. Décosterd, I., Buchser, E., Gilliard, N., Saydoff, J., Zuru, A.D. and Aebischer, P. (1998) Intrathecal implants of bovine chromatin cells alleviate mechanical allodynia in a rat model of neuropathic pain. Pain, 76: 159-166.
20. Emerich, D.F., Lindner, M.D., Winn, S.R., Chen, E.Y., Frydel, B.R. and Kordower, J.H. (1996) Implants of encapsulated human CNTF-producing fibroblasts prevent behavioral deficits and striatal degeneration in a rodent model of Huntington's disease. J. Neurosci. 16: 5168-5181.
21. Emerich, D.F., Winn, S.R., Hantraye, P.M., Peschanski, M., Chen, E.Y., Chu, Y., MDermott, P., Baetge, E.E. and Kordower, J.H. (1997) Protective effect of encapsulated cells producing neurotrophic factor CNTF in a monkey model of Huntington's disease. Nature, 386: 395-399.
22. Fisher, L.J., Jinnah, H.A., Kale, L.C., Higgins, G.A. and Gage, F.H. (1991) Survival and function of intrastriatally grafted primary fibroblasts genetically modified to produce L-dopa. Neuron, 6: 371-380.
23. Freese, A., Neve, R. and Geller, A.I. (1990) HSV-1 vector mediated neuronal gene delivery: Strategies for neuroscience and neurology. Biochem. Pharmacol., 40: 2189-2199.
24. Freese, A., Stern, M., Kaplitt, M.G., O'Connor, W.M., Abbey, M.V., O'Connor, M.J. and During, M.J. (1996) Prospects for gene therapy in Parkinson's disease. Mov. Disord., 11: 469-488.
25. Gash, D.M., Zhang, Z., Ovadia, A., Cass, W.A., Yi, A., Simmerman, L., Russell, D., Martin, D., Lapchak, P.A., Collins, F., Hoffer, B.J. and Gerhardt, G.A. (1996) Functional recovery in parkinsonian monkeys treated with GDNF. Nature, 380: 252-255.
26. Hantraye, P., Varastet, M., Peschanski, M., Riche, D., Cesaro, P., Willer, J.C. and Maziere, M. (1993) Stable parkinsonian syndrome and uneven loss of striatal dopamine fibres following chronic MPTP administration in baboons. Neuroscience, 53: 169-178.
27. Hantraye, P., Brouillet, E., Ferrante, R., Palfi, S., Dolan, R., Matthews, R.T. and Beal, M.F. (1996) Inhibition of neuronal nitric oxide synthase prevents MPTP-induced parkinsonism in baboons. Nat. Med., 2: 1017-1021.
28. Henderson, C.E., Phillips, H.S., Pollock, R.A., Davies, A.M., Lemeulle, C., Armanini, M., Simpson, L.C., Moffet, B., Vandlen, R.A., Koliatsos, V.E. and Rosenthal, A. (1994) GDNF: A potent survival factor for motoneurons present in peripheral nerve and muscle. Nature, 266: 1062-1064.
29. Hoffer, B.J., Hoffman, A., Bowenkamp, K., Huettl, P., Hudson, J., Martin, D., Lin, L.-F.H. and Gerhardt, G.A. (1994) Glial cell line-derived neurotrophic factor reverses toxin-induced injury to midbrain dopaminergic neurons in vivo. Neurosci. Lett., 182: 107-111.
30. Horellou, P., Brundin, P., Kalen, P., Mallet, J. and Björklund, A. (1990) In vivo release of dopa and dopamine from genetically engineered cells grafted to the denervated rat striatum. Neuron, 5: 393-402.
31. Joseph, J.-M., Goddard, M.B., Mills, J., Padrun, V., Zurn, A.D., Zielinski, B., Favre, J., Gardaz, J.P., Mosimann, F., Sagen, J., Christenson, L. and Aebischer, P. (1994) Transplantation of encapsulated bovine chromaffin cells in the sheep subarachnoid space: A preclinical study for the treatment of cancer pain. Cell Transplant., 3: 355-364.
32. Kang, U.J., Fisher, L.J., Joh, T.H., O'Malley, K.L. and Gage, F.H. (1993) Regulation of dopamine production by genetically modified primary fibroblasts. J. Neurosci., 13: 5203-5211.
33. Karpati, G., Lochmüller, H., Nalbantoglu, J. and Durham, H. (1996) The principles of gene therapy for the nervous system. Trends Neurosci., 19: 49-54.
34. Kawaja, M.D., Fagan, A.M., Firestein, B.L. and Gage, F.H. (1991) Intracerebral grafting of cultured autologous skin fibroblasts into the rat striatum: An assessment of graft size and ultrastructure. J. Comp. Neurol., 307: 695-706.
35. Kearns, C.M. and Gash, D.M. (1995) GDNF protects nigral dopamine neurons against 6-hydroxydopamine in vivo. Brain Res., 672: 104-111.
36. Kordower, J.H., Liu, Y.T., Winn, S.R. and Emerich, D.F. (1995) Encapsulated PC12 cell transplants into hemiparkinsonian monkeys: A behavioral, neuroanatomical, and neurochemical analysis. Cell Transplant., 4: 155-171.
37. Levivier, M., Przedborski, S., Bencsics, C. and Kang, U.J. (1995) Intrastriatal implantation of fibroblasts genetically engineered to produce brain-derived neurotrophic factor prevents degeneration of dopaminergic neurons in a rat model of Parkinson's disease. J. Neurosci., 15: 7810-7820.
38. Lin, L.-F.H., Doherty, D.H., Lile, J.D., Bektesh, S. and Collins, F. (1993) GDNF: A glial cell-line derived neurotrophic factor for midbrain dopaminergic neurons. Science, 260: 1130-1132.
39. Miller, R.G., Petajan, J.H., Bryan, W.W., Armon, C., Barohn, R.J., Goodpasture, J.C., Hoagland, R.J., Parry, G.J., Ross, M.A. and Stromatt, S.C. (1996) A placebo-controlled trial of recombinant human ciliary neurotrophic (rhCNTF) factor in amyotrophic lateral sclerosis. rhCNTF ALS Study Group. Ann. Neurol., 39: 256-260.
40. Mitsumoto, H., Ikeda, K., Holmlund, T., Greene, T, Cedarbaum, J.M., Wong, V. and Lindsay, R.M. (1994a) The effects of ciliary neurotrophic factor on motor dysfunction in wobbler mouse motor neuron disease. Ann. Neurol., 36: 142-148.
41. Mitsumoto, H., Ikeda, K., Klinkosz, B., Cedarbaum, J.M., Wong, V, and Lindsay, R.M. (1994b) Arrest of motor neuron disease in wobbler mice cotreated with CNTF and BDNF. Science, 265: 1107-1110.
42. Mittoux, V., Joseph, J.-M., Condé, F., Palfi, S., Dautry, C., Poyot, T., Bloch, J., Déglon, N., Ouary, S., Nimchinsky, E.A., Brouillet, E., Hof, P.R., Peschanski, M., Aebischer, P. and Hantraye, P. (2000) Restoration of cognitive and motor function with ciliary neurotrophic factor in a primate model of Huntington's disease. Hum. Gene Ther. (submitted).
43. O'Malley, K., Geller, A.I. (1992) Gene therapy in neurology: Potential application to Parkinson's disease. In: L. Vecsei, A. Freese, K.J, Swartz and M.F. Beal (Eds.), Neurological Disorders: Novel Experimental and Therapeutic Strategies. Ellis Horwood, West Sussex, pp. 223-248.
44. Peirone, M.A., Delaney, K., Kwiecin, J., Fletch, A. and Chang, P.L. (1998) Delivery of recombinant gene product to canines with nonautologous microencapsulated cells. Hum. Gene Ther., 9: 195-206.
45. Potter, M.A., Hymus, S., Stockley, T. and Chang L, P. (1998) Suppression of immunological response against a transgene product delivered from microencapsulated cells. Hum. Gene Ther, 9: 1275-1282.
46. Roberts, T., De Boni, U. and Sefton, M.V. (1996) Dopamine secretion by PC12 cells microencapsulate in a hydroxyethyl methacrylate-methyl methacrylate copolymer. Biomaterials, 17: 267-275.
47. Sagen, J., Pappas, G.D. and Pollard, H. (1986) Analgesia induced by isolated bovine chromaffin cells implanted in rat spinal cord. Proc. Natl. Acad. Sci. U.S.A., 83: 7522-7526.
48. Sagen, J., Wang, H., Tresco, P.A. and Aebischer, P. (1993) Transplants of immunologically isolated xenogeneic chromaffin cells provide a long-term source of pain-reducing neuroactive substances. J. Neurosci., 13(6): 2415-2423.
49. Sagot, Y., Tan, S.A., Baetge, E.E., Schmalbruch, H., Kato, A.C. and Aebischer, P. (1995) Polymer encapsulated cell lines genetically engineered to release ciliary neurotrophic factor can slow down progressive motor neuronopathy in the mouse. Eur. J. Neurosci., 7: 1313-1322.
50. Sauer, H., Rosenblad, C. and Björklund, A. (1995) GDNF but not TGF-β3 prevents delayed degeneration of nigral dopaminergic neurons following striatal 6-hydroxydopamine-lesion. Proc. Natl. Acad. Sci. U.S.A., 92: 8935-8939.
51. Sautter, J., Tseng, J.L., Braguglia, D., Aebischer, P., Spenger, C., Seiler, R.W., Widmer, H.R. and Zurn, A.D. (1998) Implants of polymer-encapsulated genetically modified cells releasing glial cell line-derived neurotrophic factor improve survival, growth, and function of fetal dopaminergic grafts. Exp. Neurol., 149: 230-236.
52. Sendtner, M., Kreutzberg, G.W. and Thoenen, H. (1990) Ciliary neurotrophic factor prevents the degeneration of motor neurons after axotomy. Nature, 345: 440-441.
53. Sendtner, M., Schmalbruch, H., Stöclki, K.A., Carroll, P., Kreutzberg, G.W. and Thoenen, H. (1992) Ciliary neurotrophic factor prevents degeneration of motor neurons in mouse mutant progressive motor neuronopathy. Nature, 358: 502-504.
54. 18F-dopa uptake and metabolism after intracerebral implantation in nonhuman primates. Cell Transplant., 6: 469-477.
55. Suhr, S.T. and Gage, F.H. (1993) Gene therapy for neurologic disease. Arch. Neurol., 30: 1252-1268.
56. Tan, S.A., Déglon, N., Zurn, A.D., Baetge, E.E., Bamber, B., Kato, A.C. and Aebischer, P. (1996) Rescue of motoneurons from axotomy-induced cell death by polymer encapsulated cells genetically engineered to release CNTF. Cell Transplant., 5: 577-587.
57. Tresco, P.A., Winn, S.R., Tan, S.A., Jaeger, C.B., Greene, L.A. and Aebischer, P. (1992) Polymer-encapsulated PC12 cells: Long-term survival and associated reduction in lesion-induced rotational behavior. Cell Transplant., 1: 255-264.
58. Tseng, J.L., Baetge, E.E., Zurn, A.D. and Aebischer, P. (1997) GDNF reduces drug-induced rotational behavior following medial forebrain bundle transection by a mechanism not involving striatal dopamine. J. Neurosci., 17: 325-333.
59. Uchida, K., Ishii, A., Kaneda, N., Toya, S., Nagatsu, T. and Kohsaka, S. (1990) Tetrahydrobiopterin-dependent production of L-dopa in NRK fibroblasts transfected with tyrosine hydroxylase cDNA: Future use for intracerebral grafting. Neurosci. Lett., 109: 282-286.
60. Uchida, K., Tsuzaki, N., Nagatsu, T. and Kohsaka, S. (1992) Tetrahydrobiopterin-dependent functional recovery in -hydroxydopamine-treated rats by intracerebral grafting of fibroblasts transfected with tyrosine hydroxylase cDNA. Dev. Neurosci., 14: 173-180.
61. Vesjada, R., Tseng, J.L., Lindsay, R.M., Acheson, A., Aebischer, P. and Kato, A.C. (1998) Synergistic but transient rescue effects of BDNF and GDNF on axotomized neonatal motoneurons. Neurosci., 84: 129-139.
62. Winn, S.R., Tresco, P.A., Zielinski, B., Greene, L.A., Jaeger, C.B. and Aebischer, P. (1991) Behavioral recovery following intrastriatal implantation of microencapsulated PC12 cells. Exp. Neurol., 113: 322-329.
63. Zurn, A.D., Baetge, E.E., Hammang, J.P., Tan, S.A. and Aebischer, P. (1994) Glial cell line-derived neurotrophic factor (GDNF), a new neurotrophic factor for motoneurons. Neuroreport, 6: 113-118.